These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 11334326)
1. Interaction between cyclosporine and acenocoumarol in a patient with nephrotic syndrome. Borrás-Blasco J; Enriquez R; Navarro-Ruiz A; Martinez-Ramirez M; Cabezuelo JB; Gonzalez-Delgado M Clin Nephrol; 2001 Apr; 55(4):338-40. PubMed ID: 11334326 [No Abstract] [Full Text] [Related]
2. Acenocoumarol and 6-mercaptopurine: an important drug interaction. Fernández MA; Regadera A; Aznar J Haematologica; 1999 Jul; 84(7):664-5. PubMed ID: 10406922 [No Abstract] [Full Text] [Related]
3. [Plausible pharmacologic interaction between fosinopril and acenocoumarol]. de Tomás ME; Sáez L; Beltrán S; Gato A Med Clin (Barc); 1997 May; 108(19):757. PubMed ID: 9324602 [No Abstract] [Full Text] [Related]
4. Interaction of OTC drug noscapine and acenocoumarol and phenprocoumon. Lokhorst B; Rolfes L; Jessurun NT Br J Clin Pharmacol; 2019 May; 85(5):1041-1043. PubMed ID: 30809820 [No Abstract] [Full Text] [Related]
5. How should microemulsified Cyclosporine A (Neoral) therapy in patients with nephrotic syndrome be monitored? Filler G Nephrol Dial Transplant; 2005 Jun; 20(6):1032-4. PubMed ID: 15814537 [No Abstract] [Full Text] [Related]
6. Benefits of cyclosporine absorption profiling in nephrotic syndrome: preprandial once-daily administration of cyclosporine microemulsion improves slow absorption and can standardize the absorption profile. Takeda A; Horike K; Onoda H; Ohtsuka Y; Yoshida A; Uchida K; Morozumi K Nephrology (Carlton); 2007 Apr; 12(2):197-204. PubMed ID: 17371346 [TBL] [Abstract][Full Text] [Related]
7. The effect of acenocoumarol on hemorheological parameters. Vayá A; Martínez M; Fernández A; Ripoll F; Moscardó F; Mira Y; Aznar J Clin Hemorheol Microcirc; 2001; 24(2):111-5. PubMed ID: 11381186 [TBL] [Abstract][Full Text] [Related]
8. Investigation of PK-PD drug-drug interaction between acenocoumarol and amoxicillin plus clavulanic acid. Delavenne X; Laporte S; Demasles S; Mallouk N; Basset T; Tod M; Girard P; Mismetti P Fundam Clin Pharmacol; 2009 Feb; 23(1):127-35. PubMed ID: 19267776 [TBL] [Abstract][Full Text] [Related]
10. The effect of nateglinide on the pharmacokinetics and pharmacodynamics of acenocoumarol. Sunkara G; Bigler H; Wang Y; Smith H; Prasad P; McLeod J; Ligueros-Saylan M Curr Med Res Opin; 2004 Jan; 20(1):41-8. PubMed ID: 14741071 [TBL] [Abstract][Full Text] [Related]
11. No effect of acenocoumarol therapy on levels of endothelial activation markers in sickle cell disease. Schnog JB; Mac Gillavry MR; Rojer RA; Meijers JC; Fijnheer R; ten Cate H; Brandjes DP; Duits AJ Am J Hematol; 2002 Sep; 71(1):53-5. PubMed ID: 12221677 [TBL] [Abstract][Full Text] [Related]
12. Lack of effect of omeprazole in oral acenocoumarol anticoagulant therapy. Vreeburg EM; De Vlaam-Schluter GM; Trienekens PH; Snel P; Tytgat GN Scand J Gastroenterol; 1997 Oct; 32(10):991-4. PubMed ID: 9361171 [TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetic study of cyclosporine in patients with nephrotic syndrome. Xiaoli D; Qiang F J Clin Pharmacol; 2009 Jul; 49(7):782-8. PubMed ID: 19448042 [TBL] [Abstract][Full Text] [Related]
14. Time course of the drug-drug interaction of acenocoumarol-miconazole. Lozano R; Frutos A Int J Clin Pharmacol Ther; 2018 Jan; 56(1):28-30. PubMed ID: 29162215 [No Abstract] [Full Text] [Related]
15. Diurnal variation in the intensity of anticoagulation in atrial fibrillation. García A; Marín F; Sánchez B; Roldán V; Marco P Stroke; 2002 Jan; 33(1):322-4. PubMed ID: 11779936 [No Abstract] [Full Text] [Related]
16. [A patient with lessened sensitivity to acenocoumarol during a period of enteral feeding]. van Iersel MD; Blenke AA; Kremer HP; Hekster YA Ned Tijdschr Geneeskd; 2004 Jun; 148(23):1155-7. PubMed ID: 15211967 [TBL] [Abstract][Full Text] [Related]